Sixty-seven percent of remote roles were for mid- to senior-level candidates, compared with just 6% that were entry-level.

To maximize the benefits of each class of drugs, this requires thoughtful plan design and careful monitoring to turn potential savings into actual benefits.

Many types of service providers would have to let employers audit them for signs of prescription drug rebate problems.

Notably, female GLP-1 users experienced a 47% reduction in hospitalizations for major cardiovascular events; approximately 50% lower incidence of ovarian cancer; and a 14% lower incidence of breast cancer compared to female non-users.